AbbVie (ABBV) Increases Buyback by $5B

The board of directors of AbbVie Inc. (NYSE: ABBV) has authorized a $5 billion increase to AbbVie's existing stock repurchase program.

Purchases may be made from time to time in management's discretion. The stock repurchase authorization permits shares to be repurchased in open market or private transactions, has no time limit and may be discontinued at any time.

You May Also Be Interested In

• Hilton Grand Vacations approves new $600M share repurchase plan
• Cosmos Health posts 29% revenue rise but widens net loss in Q2 2026
• AbbVie to Present New Data at WCLC 2026 Showcasing Innovation Across Lung Cancer Pipeline